Prenatal Particulate Air Pollution and Asthma Onset in Urban Children. Identifying Sensitive Windows and Sex

Hsiao-Hsien Leon Hsu1, Yueh-Hsiu Mathilda Chiu2, Brent A Coull3,4

  • 11 Department of Preventive Medicine.

Insights

Prenatal exposure to fine particulate matter (PM2.5) during mid-pregnancy is linked to childhood asthma, particularly in boys. Identifying sensitive exposure windows is key to understanding respiratory health impacts.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Medicine
  • Epidemiology

Background:

  • Particulate air pollution exposure during fetal development can impact lung growth.
  • The timing of exposure during gestation may influence the risk of postnatal respiratory disorders.

Purpose of the Study:

  • To identify critical windows of prenatal exposure to fine particulate matter (PM2.5) linked to asthma development in children.
  • To investigate the association between PM2.5 exposure during pregnancy and childhood asthma using an innovative methodological approach.

Main Methods:

  • Utilized a cohort of 736 children, estimating daily PM2.5 exposure via a satellite-based model.
  • Employed distributed lag models to assess the relationship between weekly PM2.5 averages and asthma diagnosis by age six.
  • Examined potential effect modification by child's sex.

Main Results:

  • Increased PM2.5 exposure between 16-25 weeks of gestation was significantly associated with asthma development by age six.
  • A significant interaction between PM2.5 exposure and sex was observed (P=0.01).
  • The association between prenatal PM2.5 exposure and asthma was primarily observed in boys.

Conclusions:

  • Higher prenatal PM2.5 exposure during midgestation is associated with asthma development by age six in boys.
  • Characterizing vulnerable developmental windows can offer insights into the mechanisms of air pollution's impact on respiratory health.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K